In a latest note to investors, a research analyst has provided a rating update for the Healthcare company, Canopy Growth
Category: Healthcare
Intercept Pharma (ICPT) Gets a Buy Rating from Oppenheimer
Oppenheimer analyst Jay Olson maintained a Buy rating on Intercept Pharma (ICPT – Research Report) today and set a price
Analysts Are Bullish on These Healthcare Stocks: Intercept Pharma (ICPT), Spark Therapeutics (ONCE)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Intercept Pharma
Analysts Conflicted on These Healthcare Names: Intercept Pharma (NASDAQ: ICPT) and Assertio Therapeutics Inc (NASDAQ: ASRT)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intercept Pharma (ICPT
Cantor Fitzgerald Keeps a Buy Rating on Spark Therapeutics (ONCE)
In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on Spark Therapeutics (ONCE – Research
Intuitive Surgical (ISRG) Receives a Buy from Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou reiterated a Buy rating on Intuitive Surgical (ISRG – Research Report) today and set a
BTIG Believes Masimo Corp (NASDAQ: MASI) Won’t Stop Here
In a report released today, Sean Lavin from BTIG maintained a Buy rating on Masimo Corp (MASI – Research Report),